Tag: ALETA-001

Cell and Gene Therapy, Industry

Cancer Research UK to support Aleta in bringing CAR-T cell therapy through clinical trials

June 23, 2021

Via: EPM Magazine

Cancer Research UK will fund, sponsor and conduct the first-in-human Phase 1/2a clinical trial of Aleta’s CAR-T cell engager candidate, ALETA-001. ALETA-001 is part of Aleta’s pipeline of therapies targeting blood cancers and solid tumours. It is being developed to […]